Aim 1: Support ALZ-NET research data collection for patients being clinically treated with Lecanemab and other anti-amyloid antibodies in the real world, with a focus on early detection of ARIA.

Aim 2: Leadership role in roll-out of digital cognitive assessment in the Keck Healthcare system.